Skip to main content

Are you Dr. Spinola?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 34 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Stanley Spinola, MD is an infectious disease specialist in Indianapolis, Indiana. He is currently licensed to practice medicine in Indiana, New York, and North Carolina. He is affiliated with Indiana University Health University Hospital and Richard L. Roudebush Veterans Affairs Medical Center.

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Public Health and General Preventive Medicine, 1984 - 1986
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Pediatrics, 1978 - 1982
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1978

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1993 - 2025
  • NC State Medical License
    NC State Medical License 1978 - 2002
  • NY State Medical License
    NY State Medical License 1987 - 1994
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1997

Publications & Presentations

PubMed

Press Mentions

  • Your Healthy Skin Germs Stay Put, Despite Cleaning
    Your Healthy Skin Germs Stay Put, Despite CleaningMay 6th, 2016
  • Skin Microbiome Influences Common Sexually Transmitted Disease
    Skin Microbiome Influences Common Sexually Transmitted DiseaseSeptember 15th, 2015

Grant Support

  • Pathogenesis Of Haemophilus Ducreyi InfectionsNational Institute Of Allergy And Infectious Diseases1995–2012
  • Biennial Symposium Of H. Ducreyi Pathogenesis And ChancroidNational Institute Of Allergy And Infectious Diseases2011
  • Human Immune Response To Haemophilus Ducreyi InfectionNational Institute Of Allergy And Infectious Diseases2007–2011
  • Training In Sexually Transmitted Diseases Including HIVNational Institute Of Allergy And Infectious Diseases2001–2011
  • Chancroid Human Challenge Unit (CHCU)National Institute Of Allergy And Infectious Diseases2009
  • Biennial Symposium On H.Ducreyi Pathogenesis And ChancroidNational Institute Of Allergy And Infectious Diseases2009
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2009
  • Midwest Sexually Transmitted Infections Topical Microbicide Cooperative ResearchNational Institute Of Allergy And Infectious Diseases2007–2009
  • Evaluation Of An Weca Mutant In Experimental Human Infection With HaemophilusNational Center For Research Resources2007–2008
  • Biennial Symposium On H.Ducreyi Pathogenesis &ChancroidNational Institute Of Allergy And Infectious Diseases2005–2008
  • Chancroid Human Challenge UnitNational Institute Of Allergy And Infectious Diseases2004–2008
  • Experimental Human Infection With Haemophilus DucreyiNational Center For Research Resources2000–2008
  • Biennial Synposium On H.Ducreyi Pathogenesis &ChancroidNational Institute Of Allergy And Infectious Diseases2006
  • Evaluation Of An Dlta Mutant In Experimental Human Infection With HaemophilusNational Center For Research Resources2006
  • Evaluation Of An Ompp2a Ompp2b Double Mutant In Experimental Human InfectionNational Center For Research Resources2005–2006
  • Midwest Stis Topical Microbicide Cooperative ResearchNational Institute Of Allergy And Infectious Diseases2004–2006
  • Experimental Human Infection With Haemophilus Ducreyi In Persons WHO Are HIVNational Center For Research Resources2004–2006
  • Experimental Human Infection With Haemophilus DecreyiNational Center For Research Resources1998–2006
  • Evaluation Of A NCAA Mutant In Experimental Human Infection With HaemophilusNational Center For Research Resources2005
  • Evaluation Of Lspa1 &Lspa2 Double Mutant In Exp. Human Infection W/H.DucreyiNational Center For Research Resources2004
  • Evaluation Of A Tada Mutant In Experimental Human Infection With H. DucreyiNational Center For Research Resources2004
  • Midwest Sexually Transmitted Diseases Cooperative ResearNational Institute Of Allergy And Infectious Diseases1999–2003
  • Sialyltransferase Mutant In Experiment Haemophilus InfecNational Center For Research Resources2000–2002
  • PAL Mutant In Experimental Haemophilus Ducreyi InfectionNational Center For Research Resources2000–2002
  • Major Outer Membrane Protein In Haemophilus DucreyiNational Center For Research Resources2000–2002
  • Cytolethal Distending Toxin Mutant In Haemophilus InfectNational Center For Research Resources2000–2002
  • CDT &Hemolysin Mutant In Haemophilus Ducreyi InfectionNational Center For Research Resources2000–2002
  • Human Immune Response To Haemophilus Ducreyi InfectionNational Institute Of Allergy And Infectious Diseases1995–2002
  • Midwest STD Cooperative Research CenterNational Institute Of Allergy And Infectious Diseases1998–2001
  • Heptosyltransferase Mutant In Experimental Infection W/ Haemophilus DucreyiNational Center For Research Resources1999
  • Hemoglobin Receptor Mutant In Experimental Infection W/ Haemophilus DNational Center For Research Resources1999
  • Role Of Hemolysin In Experimental Human Infection With Haemophilus DucreyiNational Center For Research Resources1998–1999
  • Pathogenesis Of Haemophilus Ducreyi InfectionsNational Institute Of Allergy And Infectious Diseases1993–1994
  • Pathogenesis Of Haemophilus Ducreyi InfectionsNational Institute Of Allergy And Infectious Diseases1990–1993
  • DO Antibodies Binding To H.8 Prevent MeningococcemiaNational Institute Of Allergy And Infectious Diseases1986

Hospital Affiliations